Hygiene Pharma semaglutide: what the name means and what actually matters for safe treatment

Semaglutide is the active ingredient in Wegovy, a GLP-1 receptor agonist licensed in the UK for weight management in eligible adults — the brand and manufacturer matter to safety, not just labelling.
"Hygiene Pharma" is a manufacturer name that appears in online searches for semaglutide; the only semaglutide product licensed by the MHRA for weight loss in the UK is Wegovy, made by Novo Nordisk.
The MHRA has warned publicly about counterfeit and unlicensed weight-loss injections circulating online, including fake pens containing the wrong substances entirely.
A legitimate UK supply always flows through a GPhC-registered pharmacy following a prescription issued by a qualified prescriber, there is no other safe or legal route.

Semaglutide sold under names like Hygiene Pharma is a topic that causes genuine confusion online — and that confusion matters, because semaglutide is a prescription-only medicine that requires a clinical assessment before any legitimate supply. If you have come across the term "Hygiene Pharma semaglutide" while researching Wegovy or weight-loss injections in the UK, this page explains what it refers to, what it does not mean, and why the source and supply chain of your medicine is a safety question, not just a branding one. These medicines are not assessed by the MHRA for casual or cosmetic use, and a prescriber decides suitability for each individual.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the source and licensing of your semaglutide pen is a clinical question, not a shopping preference

The biggest misconception: that semaglutide is semaglutide regardless of where it comes from

The most widespread misunderstanding in this space is that the active ingredient is all that counts. If it says semaglutide on the label, the thinking goes, it must work the same way and be equally safe. That is not how medicines regulation works, and it is not what the evidence from UK seizures shows.

Wegovy (the brand licensed by the MHRA for weight management) is manufactured by Novo Nordisk under pharmaceutical-grade conditions, with strict quality controls applied to sterility, dose accuracy and the stability of the formulation inside each pen. When semaglutide appears in online listings attributed to unfamiliar manufacturer names, there is no way for a consumer to verify the production standards, the actual concentration, or even whether the substance is genuine. The MHRA has been explicit on this: unlicensed weight-loss injections seized in the UK have contained incorrect doses, degraded product, and in some cases entirely wrong substances. Fake pens have caused hospitalisations.

So when you see a name like Hygiene Pharma attached to semaglutide in a search result, the first question is not the price, it is whether that product is licensed by the MHRA for supply in the UK, dispensed by a GPhC-registered pharmacy, and preceded by a genuine clinical assessment. If any of those conditions is missing, the risks are serious. The MHRA Yellow Card scheme allows anyone to report a suspect seller or product directly to the regulator.

What Wegovy actually is, and how semaglutide works in a licensed pen

Wegovy is a once-weekly subcutaneous injection containing semaglutide, a GLP-1 receptor agonist. GLP-1 is a gut hormone released after eating; semaglutide mimics it, signalling to the brain that you have eaten enough, slowing the rate at which the stomach empties, and reducing appetite over time. It does not burn fat directly. The effect builds gradually across the titration schedule, which a prescriber manages individually.

The NHS semaglutide medicines page describes how Wegovy is used and what to expect, it is worth reading before your consultation. Trial data from the STEP 1 study (68 weeks, published in the New England Journal of Medicine) showed an average body-weight reduction of around 15% at the 2.4mg maintenance dose alongside lifestyle changes. Those results were achieved with the licensed product, under controlled conditions, following a proper titration. They do not automatically extend to products of unknown provenance.

Wegovy is a Black Triangle medicine (▼), meaning the MHRA actively collects additional safety data on it. That is standard for newer medicines and reflects the regulator's ongoing oversight, not a reason for alarm. It does mean that reporting any side effects through Yellow Card is particularly valuable.

Searching for cheaper semaglutide: what online listings often do not tell you

Many people searching for semaglutide from lesser-known manufacturers like Raw Pharma are trying to find a more affordable route to treatment. That is entirely understandable. Private weight-loss treatment carries a real cost, and the gap between listed prices from different sellers can look significant. If you want to understand how the UK market is priced and what legitimate costs include, our Wegovy cost page breaks that down honestly.

What search results for unfamiliar brand or manufacturer names rarely show you is what is absent from the listing: no GPhC-registered dispensing pharmacy, no prescriber review, no MHRA-licensed product documentation, and no recourse if something goes wrong. Sellers offering these medicines without a clinical assessment are operating outside UK law. The MHRA seized around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million in 2025 alone, including the first illicit UK manufacturing site producing counterfeit tirzepatide pens, raided in Northampton in October 2025.

A practical check: any legitimate UK online pharmacy can be verified on the GPhC register in under a minute. If a seller is not listed there, that is your answer. The right metric for a prescription medicine is not the lowest price available, it is whether the supply chain is genuine, regulated and clinically overseen.

How legitimate semaglutide treatment works through a regulated UK pharmacy

Through a regulated service like ours at nume, the route to Wegovy, whether you are based in Edinburgh or anywhere else in the UK, is straightforward and entirely transparent. You complete a free consultation; a GPhC-registered Independent Prescriber reads your answers the same day, a real clinician, not automated software. Identity is verified with photo ID, and weight is confirmed on video. If treatment is clinically appropriate, your prescription is issued and the pen is dispensed from our GPhC-registered UK pharmacy the same day if your order arrives before noon. DPD delivers it free the next working day, in plain packaging, tracked to your door.

There are no subscriptions and no auto-renewals. Every repeat order is reviewed clinically before it is approved. If you have questions about what semaglutide treatment involves, our FAQs cover the most common ones, and our team is available seven days a week. For a broader look at how semaglutide compares to other licensed weight-loss treatments, the semaglutide overview page is a useful starting point before your consultation.

If you are ready to find out whether Wegovy is clinically suitable for you, speaking to our prescribers is the next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions